Scinovex
articleTop 10% cited

Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia

European Journal of Neuroscience · 1994 · Vol. 6(12) · pp. 1903–1912
Gary R. LewinA. RueffLorne M. Mendell

Abstract

Mechanisms underlying the hyperalgesia induced by a single systemic injection of nerve growth factor (NGF) in adult rats were studied in vivo. A single dose of NGF initiated a prolonged thermal hyperalgesia to a radiant heat source within minutes that lasted for days. Animals which had been pretreated with the mast cell degranulating compound 48/80 or either one of two specific 5-hydroxytryptamine receptor antagonists (ICS 205-930 and methiothepin) also developed an NGF-induced thermal hyperalgesia, but onset was delayed by more than 3 h. In the presence of ICS 205-930 or methiothepin the early component NGF-induced hyperalgesia was reversed and the animals responded with an initial hypoalgesia to the thermal stimuli. Whereas these results indicate a peripheral mechanism for the initial thermal hyperalgesia, the later phase (7 h-4 days after NGF) appeared to be centrally maintained, since it could be selectively blocked by the non-competitive NMDA receptor antagonist MK-801. In contrast to the almost immediate thermal hyperalgesia following a single injection of NGF, a significant mechanical hyperalgesia began only after a 7 h latency. This NGF-induced mechanical hyperalgesia was not blocked by any of the treatments that attenuated the thermal hyperalgesia, indicating that a separate mechanism may be involved. Additional electrophysiological experiments showed that NGF-induced hyperalgesia was not maintained by an increased amount of spontaneous activity in C-fibres. A final result showed that endogenous release of NGF in a model of acute inflammation (complete Freund's adjuvant-induced inflammation) may be involved in the development of thermal hyperalgesia, since it could be blocked by concomitant treatment with anti-NGF antisera. These data indicate that NGF-induced thermal and mechanical hyperalgesia are mediated by different mechanisms. The rapid onset component of thermal hyperalgesia is due to a peripheral mechanism involving the degranulation of mast cells, whereas the late component involves central NMDA receptors. In contrast, the NGF-induced mechanical hyperalgesia seems to be independent of mast cell degranulation or central NMDA receptor sites.

Pain Mechanisms and TreatmentsNeuropeptides and Animal PhysiologyPharmacological Effects of Natural CompoundsHyperalgesiaHypoalgesiaNerve growth factorChemistryAntagonistPharmacologyNociceptionEndocrinologyMedicineInternal medicine

MeSH terms

AnimalsCentral Nervous Systemp-Methoxy-N-methylphenethylamineElectrophysiologyFemaleHyperalgesiaInflammationMast CellsNerve FibersNerve Growth FactorsPain MeasurementPhysical StimulationRats, Inbred WKYReceptors, N-Methyl-D-AspartatePain Threshold

Funding

  • Regeneron Pharmaceuticals
  • National Institutes of Health
Citations
510
FWCI
10.44
field-weighted impact
References
49
Percentile
99%
vs. same field & year
Citations per year
References
Bradykinin and serotonin effects on various types of cutaneous nerve fibres
Pflügers Archiv - European Journal of Physiology · 1974 · 333 citations
Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia
European Journal of Neuroscience · 1994 · 510 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia · Scinovex